Roche Discontinues Huntington’s Gene-Silencing Program Amid Competitive Pressures
Roche has discontinued its Huntington's disease gene-silencing program, highlighting competitive pressures in neurodegenerative therapeutics. The decision comes as ARPA-H launches…
Editor's Top Picks
Federal Health Nominee’s Past Vaccine Safety Statements Under Senate Scrutiny
Sean Kaufman, nominated for a key federal health position, faces Senate scrutiny over past statements questioning vaccine safety. Senator Bill…
Submit Your Paper to GMJ
Blood test could enable early diagnosis of endometriosis, study suggests
Researchers at the University of Edinburgh have identified a distinct hormonal pattern in blood samples from people with endometriosis, raising…
Climate-Driven Mosquito Season Shifts Earlier, Threatening Disease Spread Across Northern Regions
Warming temperatures are advancing mosquito emergence by 1–2 weeks in northern temperate regions, extending the transmission season for vector-borne diseases…
America’s Small Businesses Abandon Health Insurance as Costs Spiral
Employer-sponsored health insurance in the United States is experiencing structural collapse as small businesses abandon coverage due to unsustainable costs,…
Medicine’s generational divide: Why institutions must adapt to Gen Z physicians’ values
Generation Z physicians are challenging outdated institutional norms in medicine, but the characterization of their expectations as "weakness" misses a…
Only 29% of FDA orphan drug approvals receive matching EMA authorisation
A 13-year analysis of 814 FDA orphan drug approvals found that only 29% received matching EMA authorisation with orphan status,…
Paracetamol’s Narrow Margin: Why Warnings Fail and Reformulation Must Follow
A UK student's near-fatal paracetamol overdose reveals that public warnings alone have failed. Regulatory action—mandatory reformulation and unified labeling—must replace…
Teclistamab Shows Promise in Early Multiple Myeloma Treatment: Phase 2 Trial Data Corrected
A phase 2 clinical trial of teclistamab-based induction therapy in newly diagnosed multiple myeloma has been published in Nature Medicine…
Rye Pollen Mystery Solved: Scientists Reveal 3D Structure of Compounds With Potential Cancer-Fighting Properties
Researchers have determined the precise 3D structures of two molecules in rye pollen that showed anti-tumour activity in animal studies,…